✦ LIBER ✦

Gemcitabine in locally advanced and metastatic non-small cell lung cancer (NSCLC): The central European phase II study

✍ Scribed by Zatloukal, P; Kanitz, E; Magyar, P; Jassem, J; Krzakowski, M; Pawlikci, M; Petruzelka, L; Chovan, L; Pesek, M; Janko, C; Krejcy, K

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine in locally advanced and meta

✍ Zatloukal, P; Kanitz, E; Magyar, P; Jassem, J; Krzakowski, M; Pawlicki, M; Petru 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 79 KB

A phase II study of cisplatin-gemcitabin

✍ Vázquez, F; Barón, FJ; Cueva, JF; Candamio, S; Calvo, M; Irigoyen, A; Huidobro, 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 250 KB

793 Multicenter phase II study of gemcit

✍ F. Cappuzzo; S. Novello; F. De Marinis; M. Maur; G. Scagliotti; S. Salvagni; E. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Phase II study with Taxol® (paclitaxel)

✍ Douillard, J.Y; Lerouge, D; Monnier, A; Sun, X.S; Haller, M.A; Assouline, D; Gra 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 218 KB

Gemcitabine and carboplatin in patients

✍ Kortsik, C; Albrecht, P; Elmer, A 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Ifosfamide and gemcitabine in advanced n

✍ Gatzemeier, O.; Manegold, C.; Eberhard, W.; Wilke, H.; Chomy, F.; Chomy, P.; Kha 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 90 KB